See Editorial on Page 1213
Health care costs associated with hepatocellular carcinoma: A population-based study
Version of Record online: 15 MAR 2013
Copyright © 2013 American Association for the Study of Liver Diseases
Volume 58, Issue 4, pages 1375–1384, October 2013
How to Cite
Thein, H.-H., Isaranuwatchai, W., Campitelli, M. A., Feld, J. J., Yoshida, E., Sherman, M., Hoch, J. S., Peacock, S., Krahn, M. D. and Earle, C. C. (2013), Health care costs associated with hepatocellular carcinoma: A population-based study. Hepatology, 58: 1375–1384. doi: 10.1002/hep.26231
Potential conflict of interest: Nothing to report.
Supported through provision of data by the Institute for Clinical Evaluative Sciences (ICES) and Cancer Care Ontario (CCO) and through funding support to the ICES from an annual grant by the Ministry of Health and Long-Term Care and the Ontario Institute for Cancer Research (OICR). The opinions, results, and conclusions reported in this paper are those of the authors. No endorsement by ICES, CCO, OICR or the Government of Ontario is intended or should be inferred. Hla-Hla Thein is supported by the Ontario Institute for Cancer Research Health Services Research Program New Investigator Award at the Dalla Lana School of Public Health, University of Toronto. Murray Krahn is supported by the F. Norman Hughes Chair in Pharmacoeconomics at the Faculty of Pharmacy, University of Toronto, and in part by the Toronto Health Economics and Technology Assessment Collaborative through the Ontario Ministry of Health and Long-Term Care.
This work was presented in part at the Canadian Cancer Research Conference, November 2011, Toronto, Canada (poster presentation); the Canadian Symposium on Hepatitis C Virus, February 2012, Montreal, Canada (oral presentation); the Ontario Institute for Cancer Research and Cancer Care Ontario, Health Services Research Program 4th Annual Meeting, May 2012, Toronto, Canada (poster presentation); and the 2012 Canadian Association for Health Services and Policy Research conference, Montreal, Canada (oral presentation). It was also accepted for a poster presentation at the American Association for the Study of Liver Diseases in November 2012.
- Issue online: 1 OCT 2013
- Version of Record online: 15 MAR 2013
- Accepted manuscript online: 8 JAN 2013 05:29PM EST
- Manuscript Accepted: 2 DEC 2012
- Manuscript Received: 23 AUG 2012
- 21Lifetime costs of colon and rectal cancer management in Canada. Chronic Dis Can 2003;24:91–101., , , , , , et al.
- 29Joinpoint regression program (version 3). National Cancer Institute. http://srab.cancer.gov/joinpoint/. Accessed September 16,2011.
- 31Automated geographic coding based on the Statistics Canada Postal Code Conversion Files, including postal codes to December 2003. Ottawa: Health Analysis and Measurement Group, Statistics Canada; 2004. abacus.library.ubc.ca/bitstream/10573/41318/1/msword-pccf4d.pdf. Accessed October 13,2011..
- 33Constructing a control group using multivariate matched sampling methods that incorporate the propensity score. Am Stat 1985;39:33–38., .
- 35The Statistical Analysis of Failure Time Data.New York, NY:Wiley;1980., .
- 36Statistics Canada. Available at: http://www.statcan.gc.ca/estat/estat-eng.htm. Accessed Jan 31,2012.
- 41Progress Report on Cancer Control in Canada. www.phac-aspc.gc.ca. Accessed February 25,2012.